ACADIA Pharmaceuticals Inc (ACAD) — Cash Flow Quality Index
ACADIA Pharmaceuticals Inc (ACAD) has a Cash Flow Quality Index of 9.34x as of March 2026. Operating cash flow of $33.98 Million exceeds net income of $3.64 Million, indicating high earnings quality where cash backs reported profits. Explore ACADIA Pharmaceuticals Inc strategic investment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
ACADIA Pharmaceuticals Inc Cash Flow Quality Index (2010–2025)
Historical Cash Flow Quality Index for ACADIA Pharmaceuticals Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check ACAD tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for ACADIA Pharmaceuticals Inc (2010–2025)
Year-by-year earnings quality comparison for ACADIA Pharmaceuticals Inc. For live market cap and the full company financial profile, see how much is ACADIA Pharmaceuticals Inc worth.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 0.28x | $109.84 Million | $391.00 Million | ▼ -59.7% |
| 2024 | 0.70x | $157.72 Million | $226.45 Million | ▲ +198.5% |
| 2010 | -0.71x | $-10.70 Million | $15.14 Million | — |